The HBsAg protein is crucial in the development of the Hepatitis B vaccine. The vaccine is designed to trigger the body's immune response against this antigen, helping to protect against future HBV infections. By generating antibodies specifically targeting HBsAg, the immune system can effectively neutralize the virus if exposed.
